Differential effects of androgens on coronary blood flow regulation and arteriolar diameter in intact and castrated swine

Biology of Sex Differences

Volumn 3, Issue 1, 2012, Pages

  O'Connor, Erin K ^a   Ivey, Jan R ^a   Bowles, Douglas K ^a,b  

^a UNIVERSITY OF MISSOURI   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

Androgen receptor; Androgens; Coronary blood flow; Porcine; Vasomotor

Indexed keywords

EID: 84892940747     PISSN: None     EISSN: 20426410     Source Type: Journal    
DOI: 10.1186/2042-6410-3-10     Document Type: Article

References (42)

1. Laughlin GA, Barrett-Connor E, Bergstrom J: Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 2008, 93:68-75.
2. Simon D, Charles MA, Nahoul K, Orssaud G, Kremski J, Hully V, Joubert E, Papoz L, Eschwege E: Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study. J Clin Endocrinol Metab 1997, 82:682-685. (Pubitemid 27068651)
3. Jankowska EA, Filippatos G, Ponikowska B, Borodulin-Nadzieja L, Anker SD, Banasiak W, Poole-Wilson PA, Ponikowski P: Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure. J Card Fail 2009, 15:442-450.
4. Vikan T, Johnsen SH, Schirmer H, Njolstad I, Svartberg J: Endogenous testosterone and the prospective association with carotid atherosclerosis in men: the Tromso study. Eur J Epidemiol 2009, 24:289-295.
5. Bernini G, Versari D, Moretti A, Virdis A, Ghiadoni L, Bardini M, Taurino C, Canale D, Taddei S, Salvetti A: Vascular reactivity in congenital hypogonadal men before and after testosterone replacement therapy. J Clin Endocrinol Metab 2006, 91:1691-1697.
6. Phillips GB, Pinkernell BH, Jing TY: The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb 1994, 14:701-706.
7. Lu YL, Kuang L, Zhu H, Wu H, Wang XF, Pang YP, Wang NJ, Yu DL: Changes in aortic endothelium ultrastructure in male rats following castration, replacement with testosterone and administration of 5alpha-reductase inhibitor. Asian J Androl 2007, 9:843-847. (Pubitemid 350090508)
8. Tharp DL, Masseau I, Ivey J, Ganjam VK, Bowles DK: Endogenous testosterone attenuates neointima formation after moderate coronary balloon injury in male swine. Cardiovasc Res 2009, 82:152-160.
9. Webb CM, Elkington AG, Kraidly MM, Keenan N, Pennell DJ, Collins P: Effects of oral testosterone treatment on myocardial perfusion and vascular function in men with low plasma testosterone and coronary heart disease. Am J Cardiol 2008, 101:618-624. (Pubitemid 351625084)
10. Yaron M, Greenman Y, Rosenfeld JB, Izkhakov E, Limor R, Osher E, Shenkerman G, Tordjman K, Stern N: Effect of testosterone replacement therapy on arterial stiffness in older hypogonadal men. Eur J Endocrinol 2009, 160:839-846.
11. Qiu Y, Yanase T, Hu H, Tanaka T, Nishi Y, Liu M, Sueishi K, Sawamura T, Nawata H: Dihydrotestosterone suppresses foam cell formation and attenuates atherosclerosis development. Endocrinology 2010, 151:3307-3316.
12. Ong PJ, Patrizi G, Chong WC, Webb CM, Hayward CS, Collins P: Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease. Am J Cardiol 2000, 85:269-272. (Pubitemid 30026117)
13. Webb CM, McNeill JG, Hayward CS, de Zeigler D, Collins P: Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. Circulation 1999, 100:1690-1696. (Pubitemid 29485250)
14. Chou TM, Sudhir K, Hutchison SJ, Ko E, Amidon TM, Collins P, Chatterjee K: Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation 1996, 94:2614-2619. (Pubitemid 26403593)
15. Deenadayalu VP, White RE, Stallone JN, Gao X, Garcia AJ: Testosterone relaxes coronary arteries by opening the large-conductance, calciumactivated potassium channel. American Journal of Physiology-Heart & Circulatory Physiology 2001, 281:H1720-H1727.
16. Jones RD, English KM, Jones TH, Channer KS: Testosterone-induced coronary vasodilatation occurs via a non-genomic mechanism: evidence of a direct calcium antagonism action. Clin Sci (Lond) 2004, 107:149-158. (Pubitemid 39070931)
17. Molinari C, Battaglia A, Grossini E, Mary DA, Vassanelli C, Vacca G: The effect of testosterone on regional blood flow in prepubertal anaesthetized pigs. J Physiol (Lond) 2002, 543:365-372. (Pubitemid 34947321)
18. Yue P, Chatterjee K, Beale C, Poole-Wilson PA, Collins P: Testosterone relaxes rabbit coronary arteries and aorta. Circulation 1995, 91:1154-1160.
19. Starka L: Epitestosterone. J Steroid Biochem Mol Biol 2003, 87:27-34. (Pubitemid 37421336)
20. Sanders B: Sex, drugs, and sports: Prostaglandins, epitestosterone and sexual development. Med Hypotheses 2007, 69:829-835. (Pubitemid 47248122)
21. Havlikova H, Hill M, Hampl R, Starka L: Sex and age related changes in epitestosterone in relation to pregnenolone sulfate and testosterone in normal subjects. J Clin Endocrinol Metab 2002, 87:2225-2231. (Pubitemid 34521513)
22. Jones RD, Ruban LN, Morton IE, Roberts SA, English KM, Channer KS, Jones TH: Testosterone inhibits the prostaglandin F2alpha-mediated increase in intracellular calcium in A7r5 aortic smooth muscle cells: evidence of an antagonistic action upon store-operated calcium channels. J Endocrinol 2003, 178:381-393. (Pubitemid 37220165)
23. Jones RD, Pugh PJ, Jones TH, Channer KS: The vasodilatory action of testosterone: a potassium-channel opening or a calcium antagonistic action? Br J Pharmacol 2003, 138:733-744. (Pubitemid 36390629)
24. Murphy JG, Khalil RA: Decreased [Ca(2+)](i) during inhibition of coronary smooth muscle contraction by 17beta-estradiol, progesterone, and testosterone. Journal of Pharmacology & Experimental Therapeutics 1999, 291:44-52. (Pubitemid 29451571)
25. Sieveking DP, Lim P, Chow RW, Dunn LL, Bao S, McGrath KC, Heather AK, Handelsman DJ, Celermajer DS, Ng MK: A sex-specific role for androgens in angiogenesis. J Exp Med 2010, 207:345-352.
26. Hanke H, Lenz C, Spindler KD, Weidemann W: Effect of testosterone on plaque development and androgen receptor expression in the arterial vessel wall. Circulation 2001, 103:1382-1385. (Pubitemid 32220628)
27. Liu PY, Christian RC, Ruan M, Miller VM, Fitzpatrick LA: Correlating Androgen and Estrogen Steroid Receptor Expression with Coronary Calcification and Atherosclerosis in Men without Known Coronary Artery Disease. J Clin Endocrinol Metab 2005, 90:1041-1046. (Pubitemid 40279231)
28. Yu J, Akishita M, Eto M, Ogawa S, Son BK, Kato S, Ouchi Y, Okabe T: Androgen receptor-dependent activation of endothelial nitric oxide synthase in vascular endothelial cells: role of phosphatidylinositol 3-kinase/akt pathway. Endocrinology 2010, 151:1822-1828.
29. Bowles DK, Heaps CL, Turk JR, Maddali KK, Price EM: Hypercholesterolemia inhibits L-type calcium current in coronary macro-, not microcirculation. J Appl Physiol 2004, 96:2240-2248. (Pubitemid 38661508)
30. Tharp DL, Wamhoff BR, Turk JR, Bowles DK: Upregulation of intermediate conductance Ca2 +-activated K + channel (IKCa1) mediates phenotypic modulation of coronary smooth muscle. Am J Physiol Heart Circ Physiol 2006, 291:H2493-H2503.
31. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001, 25:402-408. (Pubitemid 34164012)
32. Bowles DK, Maddali KK, Ganjam VK, Rubin LJ, Tharp DL, Turk JR, Heaps CL: Endogenous testosterone increases L-type Ca2+ channel expression in porcine coronary smooth muscle. Am J Physiol Heart Circ Physiol 2004, 287:H2091-H2098. (Pubitemid 39430748)
33. Malkin CJ, Jones RD, Jones TH, Channer KS: Effect of testosterone on ex vivo vascular reactivity in man. Clin Sci (Lond) 2006, 111:265-274. (Pubitemid 44599873)
34. English KM, Jones RD, Jones TH, Morice AH, Channer KS: Aging reduces the responsiveness of coronary arteries from male Wistar rats to the vasodilatory action of testosterone. Clinical Science 2000, 99:77-82. (Pubitemid 30479395)
35. Komaru T, Kanatsuka H, Shirato K: Coronary microcirculation-Physiology and pharmacology. Pharmacology and Therapeutics 2000, 86:217-261.
36. Bennett NC, Gardiner RA, Hooper JD, Johnson DW, Gobe GC: Molecular cell biology of androgen receptor signalling. Int J Biochem Cell Biol 2010, 42:813-827.
37. Perusquia M, Stallone JN: Do androgens play a beneficial role in the regulation of vascular tone? Nongenomic vascular effects of testosterone metabolites. Am J Physiol Heart Circ Physiol 2010, 298:H1301-H1307.
38. Ma R, Wu S, Lin Q: Homologous up-regulation of androgen receptor expression by androgen in vascular smooth muscle cells. Horm Res 2005, 63:6-14.
39. Choate JV, Resko JA: Androgen receptor immunoreactivity in intact and castrate guinea pig using antipeptide antibodies. Brain Res 1992, 597:51-59.
40. Antonio J, Wilson JD, George FW: Effects of castration and androgen treatment on androgen-receptor levels in rat skeletal muscles. J Appl Physiol 1999, 87:2016-2019.
41. Brandstetter AM, Pfaffl MW, Hocquette JF, Gerrard DE, Picard B, Geay Y, Sauerwein H: Effects of muscle type, castration, age, and compensatory growth rate on androgen receptor mRNA expression in bovine skeletal muscle. J Anim Sci 2000, 78:629-637.
42. Sader MA, McGrath KC, Hill MD, Bradstock KF, Jimenez M, Handelsman DJ, Celermajer DS, Death AK: Androgen receptor gene expression in leucocytes is hormonally regulated: implications for gender differences in disease pathogenesis. Clin Endocrinol (Oxf) 2005, 62:56-63. (Pubitemid 40175284)